AL Notes: Yankees, Joyce, Twins, Astros

A 2015 postseason appearance for the Yankees will likely hinge on improvements from costly middle-of-the-order hitters like Carlos Beltran, Brian McCann, and Mark Teixeira, writes Joel Sherman of the New York Post. Barring a surprise, last year’s big spending leaves the club with few options to add significant run production to its lineup, explains Sherman.

Here’s more from the American League:

• Rays outfielder Matt Joyce says that he believes he will be dealt in the offseason, as Marc Topkin of the Tampa Bay Times reports. The 30-year-old is entering his final year of arbitration eligibility after earning $3.7MM this season. “I think there’s a good chance [of a trade], just knowing the organization and how they operate and how many young guys that they have in the outfield and coming up through the system,” said Joyce. The left-handed hitting outfielder owns a .252/.348/.379 slash over 477 plate appearances this year, continuing a trend of declining power numbers since he broke into the league.
• The top offseason priority for the Twins will be the rotation, GM Terry Ryan tells Mike Berardino of the St. Paul Pioneer Press (Twitter link). Of course, that seemed to be the case last year, when the team made significant commitments to free agent hurlers Ricky Nolasco, Phil Hughes, and Mike Pelfrey. Only Hughes has been a hit, though he does look to be a legitimate bargain.
• For the Astros, meanwhile, the bullpen figures to receive the most attention this winter, MLB.com’s Brian McTaggart reports. GM Jeff Luhnow said that the club might have seen a significant jump had two of its expected pen pieces — Matt Albers and Jesse Crain — been able to contribute more innings. Looking forward, he said that the team has no choice but to take its chances adding relief arms. “We’ve reflected on our process last year and made some improvements and we feel good about that,” said Luhnow. “It’s always a risk with relievers because there’s a lot of variables year to year, but we feel good we’ll identify the right guys and go after them, and hopefully get a good roll of the dice this time in terms of the health side of the equation.”